triumph 1 trial retatrutide triple agonist clinical trials ⭐️topline results from TRIUMPH-1, a Phase 3 evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon hormone receptor agonist, in adults with obesity or “overweight” retatrutide Retatrutide Weight Loss Results:Trial Data
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15



























